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Background: Increased risk of schizophrenia in adolescent males indicates that a link between the development of
dopamine-related psychopathology and testosterone-driven brain changes may exist. However, contradictions as to
whether testosterone increases or decreases dopamine neurotransmission are found and most studies address this
in adult animals. Testosterone-dependent actions in neurons are direct via activation of androgen receptors (AR) or
indirect by conversion to 17β-estradiol and activation of estrogen receptors (ER). How midbrain dopamine neurons
respond to sex steroids depends on the presence of sex steroid receptor(s) and the level of steroid conversion
enzymes (aromatase and 5α-reductase). We investigated whether gonadectomy and sex steroid replacement could
influence dopamine levels by changing tyrosine hydroxylase (TH) protein and mRNA and/or dopamine breakdown
enzyme mRNA levels [catechol-O-methyl transferase (COMT) and monoamine oxygenase (MAO) A and B] in the
adolescent male rat substantia nigra. We hypothesized that adolescent testosterone would regulate sex steroid
signaling through regulation of ER and AR mRNAs and through modulation of aromatase and 5α-reductase mRNA
levels.
Results: We find ERα and AR in midbrain dopamine neurons in adolescent male rats, indicating that dopamine
neurons are poised to respond to circulating sex steroids. We report that androgens (T and DHT) increase TH
protein and increase COMT, MAOA and MAOB mRNAs in the adolescent male rat substantia nigra. We report that
all three sex steroids increase AR mRNA. Differential action on ER pathways, with ERα mRNA down-regulation and
ERβ mRNA up-regulation by testosterone was found. 5α reductase-1 mRNA was increased by AR activation, and
aromatase mRNA was decreased by gonadectomy.
Conclusions: We conclude that increased testosterone at adolescence can shift the balance of sex steroid signaling
to favor androgenic responses through promoting conversion of T to DHT and increasing AR mRNA. Further,
testosterone may increase local dopamine synthesis and metabolism, thereby changing dopamine regulation
within the substantia nigra. We show that testosterone action through both AR and ERs modulates synthesis of sex
steroid receptor by altering AR and ER mRNA levels in normal adolescent male substantia nigra. Increased sex
steroids in the brain at adolescence may alter substantia nigra dopamine pathways, increasing vulnerability for the
development of psychopathology.
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Androgens and estrogens produced by the gonads influ-
ence brain function including cognitive, motor and mo-
tivational behaviors and neurotransmitter release in
midbrain dopamine circuits. Schizophrenia, character-
ized by hallucinations and delusions resulting from
hyperactivity of the subcortical dopaminergic system (es-
pecially dorsal caudate) [1,2], affects males more severely
than females [3] with the highest rate of onset seen in
adolescent males [4]. Male adolescence involves a rapid
increase in testosterone production leading to increased
blood testosterone levels [5]. The increased risk of
schizophrenia in male adolescents suggests that testos-
terone may directly induce transcriptional and matur-
ational changes in midbrain dopamine neurons. However,
molecular evidence supporting that sex steroids can
change gene expression during the adolescent matur-
ation of midbrain dopamine neurons does not cur-
rently exist.
Sex steroids activate ligand-dependent nuclear recep-
tors. Testosterone initiates changes in gene expression
via direct activation of androgen receptors (AR) or can
interact with estrogen receptors after aromatization.
Testosterone can be converted to the non-aromatisable
androgen, dihydrotestosterone (DHT) by 5α-reductase
enzymes (5αR) [6]. DHT is a pure androgen with greater
potency at AR than testosterone and can initiate gene
expression only via AR. Testosterone is also converted
to estradiol by the cytochrome p450 enzyme, aromatase
(Cyp19A1), to activate nuclear estrogen receptors, ERα
and ERβ. All three sex steroid receptors (ERα, ERβ and
AR) exist in adult rodent midbrain [7-11]. Two 5αR iso-
zymes, 5αR-1 and 5αR-2, are expressed in rodent and
human brain during adulthood [12] and aromatase is
expressed in the midbrain [13]. Androgens differentially
control 5αR mRNA levels in the rat prefrontal cortex [14]
and high levels of 5αR activity have been detected in rat
midbrain homogenates [15]. However, it is unknown
whether testosterone can regulate the enzymes involved in
steroid conversion in the adolescent male substantia nigra.
We hypothesized that testosterone may change aromatase
and 5αR mRNAs to alter sex steroid signaling over the
period of adolescence in male rat substantia nigra.
Studies in rodents disagree as to how sex steroids
modulate midbrain dopamine circuits. Some studies in
adult male rats suggest that dopamine neurons are
inhibited by circulating testosterone, as castration caused
increased striatal dopamine release, increased locomotion
and augmented the behavioral response to dopamine-
potentiating drugs of abuse [16-18]. Other studies suggest
the opposite, where exogenous testosterone can increase
striatal dopamine levels and dopamine turnover in adult
male rats [19,20]. Anatomically, testosterone can increase
dopaminergic neuron axon density in targets [7], butmay also lead to a decreased number of dopamine neu-
rons in the midbrain [21]. Most studies have been car-
ried out in adult rodents, but studies focusing on the
adolescent period of brain development are imperative
to understand the involvement of sex steroids in psycho-
pathologies that emerge (or worsen) during adolescence.
In our study, we investigated whether gonadectomy
and exogenous androgens or estradiol are able to influ-
ence dopamine neurons by changing tyrosine hydroxy-
lase (TH) levels, the rate limiting enzyme in the
production of dopamine and/or by changing the levels
of mRNA encoding for enzymes involved in dopamine me-
tabolism such as catechol-O-methyl transferase (COMT)
and monoamine oxygenase (MAO) A and B in the sub-
stantia nigra (SN) of adolescent male rats. We also tested
the extent to which sex steroid receptor mRNA expres-
sion changes in response to testosterone and estradiol in
male adolescence in the substantia nigra.
Methods
Animal experiments
All animal experiments were approved by the Animal
Care and Ethics Committee of the University of New
South Wales in accordance with the National Health
and Medical Research Council of Australia’s Code of
Practice for the Care and Use of Animals for Experimental
Purposes, which also conforms to standard international
guidelines. Male Sprague–Dawley rats were used for all
experiments (Animal Resource Centre, Perth, WA,
Australia). Rats were group housed (3-4/cage) in 12/12 hr
light/dark phases with constant humidity and temperature
and free access to water and standard rat chow.
Gonadectomy and sex steroid replacement
Adolescent male rats were gonadectomised at 45 days of
age, prior to the adolescent testosterone increase, and
given continuous replacement testosterone (T), dihydro-
testosterone (DHT) or 17β-estradiol (estradiol, E) by
subdermal silastic implant [22-24] for two weeks. By this
age, intact animals have experienced the increase in tes-
tosterone associated with adolescence. There were five
groups (~15 rats per group): intact (Intact), gonadectomy
alone (Gdx); gonadectomy plus testosterone (Gdx+T);
gonadectomy plus DHT (Gdx+DHT), gonadectomy plus
estradiol (Gdx+E). Male rats (45 days old) were anaesthe-
tized with an intraperitoneal (i.p.) injection of ketamine
hydrochloride (60 mg/kg) and xylazine hydrochloride
(10 mg/kg) (Provet, Castle Hill, Australia). The intact ani-
mals underwent sham abdominal surgery but gonads were
left in place. Silastic implants were placed under the skin
between the shoulder blades at time of gonadectomy. Gdx
and Intact groups were given empty implants. Implants
were 1 cm long, internal diameter 1.47 mm, outer diam-
eter 1.95 mm (ends sealed with silastic adhesive). These
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achieve supraphysiological, steady-state hormone levels
and maintain seminal vesicle weights equal to that in un-
treated animals [23,25]. Seminal vesicles depend on an-
drogen action for normal development and maintenance
of structural and functional integrity [26]. Weight of sem-
inal vesicles at the end of experiment served as an index
of the restoration of androgen action by the implants as
previously reported [25].
At 60 days of age rats were anaesthetized with 60 mg/kg
sodium pentobarbital (Euthal, Delvet, Seven Hills,
Australia). Brain was removed from the skull and a tissue
block containing the midbrain was dissected following the
Rat Brain Atlas as a guide [27]. The block was trimmed
transversely at the cerebral aqueduct and two lateral seg-
ments of midbrain on either side of the ventral tegmental
area (VTA) containing the SN were collected. Trunk
blood was collected on day of euthanasia in 0.8 ml serum
gel tubes (Z serum sep MiniCollect tube, Greiner Bio
One, Wemmel, Belgium) and serum collected by centrifu-
gation. Left and right hemisphere midbrain segments in-
cluding SN were randomly assigned for either protein or
RNA extraction.
Immunohistochemistry
For immunohistochemical studies five normal intact
male rats (50–53 days old) were deeply anaesthetized
with pentobarbital (Euthal) followed by transcardial per-
fusion with 4% paraformaldehyde (PFA, pH 7.2). Mid-
brain was dissected in the coronal plane and post-fixed
(4% PFA) overnight, washed with phosphate buffered sa-
line (PBS) and cryoprotected in 30% sucrose/PBS.
Midbrain sections (40 μm) were collected in PBS and
sections from each brain between Bregma −5.52 and
−5.64 mm was incubated for 1 h with 10% horse serum
(Sigma) and 0.1% Triton X-100 (Sigma) in PBS. This was
followed by incubation with primary antibodies over-
night at 4°C, washes and incubation with fluorescence-
conjugated secondary antibodies for 2 h at room
temperature. The antisera used were: TH (host species
mouse, 1:500; MAB318, Millipore, Temecula, CA, USA)
or TH (host species rabbit, 1:500; AB152, Millipore),
ERα (host species mouse, 1:50; 6 F-11, Nova Castra,
Leica-Microsystems, Wetzlar, Germany) and AR (host spe-
cies rabbit, 1:200, PA1-110, Thermo Scientific, Australia,
Scoresby, Victoria). ERβ immunohistochemistry was not
performed as there are currently no well-validated com-
mercial ERβ antibodies available. Primary antibody bind-
ing was visualized with fluorophore-conjugated species-
specific secondary antibodies (donkey-anti-mouse-Alexa
Fluor488 and 594, donkey-anti-rabbit-Alexa Fluor488 and
594, all 1:500, Life Technologies, Carlsbad, CA, USA). Sec-
tions incubated with only secondary antibody or with each
primary antibody with the alternate (incorrect) secondaryantibody confirmed that no fluorescent signal was due to
non-specific or cross-over binding. Nuclei were visualized
by incubation with 1 μg/ml DAPI (Sigma). Sections were
mounted with glycerol/PBS (Citifluor AF1, London, UK).
Sections were viewed under a Nikon Eclipse 80i fluores-
cence microscope (Nikon) with a CX9000 digital camera
attached (MBF Biosciences, Williston, VT, USA). SN and
VTA were demarcated under low power (4x) using
StereoInvestigator (v8.27, MBF Biosciences) and referring
to a Rat Brain Atlas [27]. Under higher power (20x) using
StereoInvestigator, TH positive cells (100–200) were iden-
tified within the SN pars compacta, they were then
assessed for receptor immunoreactivity and percentage
of TH positive neurons expressing either receptor was
determined. Images were also collected on a Nikon C1
laser scanning confocal unit (Nikon D-Eclipse C1,
Nikon Australia) attached to a fluorescence microscope
(Nikon Eclipse 90i). Images were acquired digitally and
processed using the software EZ-C1 (v 3.5) for Nikon
C1 confocal microscopes (Nikon Australia).
Immunoblotting
The substantia nigra blocks were homogenized [0.1 M
Tris, pH 7.5, 50% glycerol, proteinase inhibitor cocktail
(Sigma Cat# P8340) and aprotinin (0.015 mM, Sigma, St
Louis, MO, USA)] using a handheld electric homogenizer
(Polytron, Kinematica, Lucerne, Switzerland). Protein con-
centration was determined using the Bradford protein
assay (Sigma). An aliquot of each sample was combined
and used as a standard and run in duplicate on each gel to
allow standardization between blots (internal control).
Standard curves with between 0.5 and 20 μg SN protein
were run and TH expression was determined to be within
a linear range using 3 μg protein. SDS-PAGE (10% acryl-
amide) was performed on 3 μg of protein per sample. Pro-
teins were transferred to nitrocellulose (45 μm, Biorad,
CA, USA). Primary antibodies were anti-TH (host spe-
cies mouse, 1:5000; Chemicon) and anti-β-actin (host
species rabbit, 1:5000; MAB1501, Millipore). Secondary
antibodies were goat anti-mouse or anti-rabbit horse-
radish peroxidase (HRP) conjugated (1:4000, Millipore).
Immunoreactive bands were detected using the LumiGlo
detection kit (LumiGlo Reagent; Cell Signaling, Danvers,
MA, USA) on hyperfilm (Amersham, GE Healthcare,
Uppsala, Sweden). The immunoblots were scanned and
band densities converted to numerical values using ImageJ
software (ImageJ 1.43u, National Institutes of Health,
USA). Relative intensity of TH bands were normalized to
relative intensity of β-actin bands.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from substantia nigra samples in
800–1000 μl TRIzol reagent (Life Technologies Inc., Grand
Island, NY, USA) with a handheld electric homogenizor
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was quantified using a ND-1000 Spectrophotometer
(Nanodrop Technologies, Wilmington, USA). RNA in-
tegrity (RIN) was assessed with high resolution capil-
lary electrophoresis (Agilent Bioanalyzer 2100, Agilent
Technologies, Palo Alto, CA, USA). Two separate ali-
quots of 3 μg RNA from each sample were reverse tran-
scribed to cDNA with SuperScript III First-Strand
Synthesis Supermix and random hexamers, according to
the manufacturer’s protocol (Life Sciences). A parallel reac-
tion was performed without reverse transcriptase as a nega-
tive control. The 2 aliquots of cDNA from each sample
were pooled and diluted for RT-PCR.
Quantitative Real-Time PCR (qPCR)
Messenger RNA (mRNA) levels of genes of interest were
measured by TaqMan Gene Expression Assays (Applied
Biosystems, Foster City, CA, USA) using an ABI Prism
7900HT Fast Real-Time PCR System and a 384-well for-
mat. Expression of three housekeeping genes, beta-
glucuronidase (GusB), 18 S ribosomal RNA (18 S rRNA)
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH),
was used to calculate the normalizing control for gene ex-
pression (termed geometric mean), and were selected on
the basis that they were unchanged by the treatment. The
Taqman probes used were: GusB (Rn00566655); 18 s rRNA
(Hs99999901); GAPDH (Rn01775763). The geometric
mean of the three housekeeping genes was calculated as
described previously [28]. There were no group differ-
ences when the geomean of the three housekeepers was
compared (F=1.67, df=4, p=0.168). Genes of interest
were targeted by the following Taqman probes (Applied
Biosystems): TH (Rn00562500), COMT (Rn00561037),
MAOA (Rn01430950), MAOB (Rn00566203), ERα
(Rn01640372), ERβ (Rn00562610), AR (Rn00560747)
and Cyp19A1 (Rn00567222), 5αR-1 (Rn00567064) and
5αR-2 (Rn00575595, 5αR-2 mRNA levels in midbrain
were too low to be accurately quantitated). Samples were
run alongside a seven point standard curve using serial
dilutions of cDNA derived from midbrain RNA pooled
from a subset of 25 rats (taken from all treatment groups).
No template controls were included which produced no
signal for any mRNA examined. Measurements were per-
formed in triplicate. PCR cycling conditions were: 50°C
for 2 minutes, 95°C for 10 minutes, 50 cycles of 95°C for
15 seconds and 60°C for 1 minute. PCR data were cap-
tured with Sequence Detector Software (SDS version 2.4,
Applied Biosystems). SDS software plotted real-time fluor-
escence intensity and the threshold was set within the lin-
ear phase of the amplification profiles.
Sex steroid measurements
Testosterone (T), dihydrotestosterone (DHT) and 17β-
estradiol (estradiol, E) were quantified in extracts of serumusing a stable isotope dilution liquid chromatography-
tandem mass spectroscopy (LC-MS/MS) method as
described [29] and adapted for rodents [30]. The limit of
quantitation for this method is 0.025 ng/ml T, 0.1 ng/ml
DHT and 5 pg/ml E. T and DHT were also measured in
serum extracts using a gas chromatography MS (GC-MS)
method adapted from Horning et al., [31] (data presented
in additional material).
Statistics
Unless otherwise stated statistical analyses were con-
ducted using SPSS software (IBM SPSS Statistics, ver-
sion 19) and p < 0.05 was considered statistically
significant. Seminal vesicle and body weight (g) data are
shown as mean ± standard error of the mean (SEM). Im-
munoblotting data are presented as percent change of
relative intensity compared to the Gdx group ± SEM.
Immunoblotting data were normalized to β-actin expres-
sion and population outliers removed by performing
Grubbs test for outliers (GraphPad Software). Data was
then analyzed by one-way ANOVA followed by Fisher’s
least significant differences (LSD), post hoc.
QPCR data are presented as percent change of mRNA
levels relative to the Gdx group ± SEM. Outlier detec-
tion of the triplicates obtained from the qPCR raw data
was used to exclude measurement errors [32]. qPCR raw
data was normalized by the geomean of the house-
keepers. Population outliers were removed by perform-
ing Grubb’s test on the normalized data and data were
analyzed by one-way ANOVA followed by Fisher’s LSD.
Results
Confirmation of sex steroid replacement by organ weight
There were no significant differences in overall body
growth between any of the five experimental groups (the
mean - of all 5 groups - increase in body weight over the
course of study was 44.0 ± 2.0%) (Figure 1A). There were
no significant group differences in brain weight (results
not shown). There was a significant effect of treatment
group when examining seminal vesicle weights (F=149.2,
df=4, p < 0.0001). Gdx reduced seminal vesicles to 9.0%
weight of Intact group (Figure 1B). Seminal vesicles were
maintained at 94.2% of intact weights by replacement
testosterone and at 44% of intact weights by replacement
DHT. Estradiol replacement had no effect on seminal
vesicle weights such that the Gdx+E group was not sig-
nificantly different to the Gdx group.
Confirmation of sex steroid replacement by blood levels
DHT and T were measured by LC-MS/MS and GC-MS
methods. Estradiol was detectable only by LC-MS/MS.
Comparisons of GC-MS and LC-MS/MS androgen mea-
surements in sera samples are included in additional mater-





























































Figure 1 Effect of gonadectomy and sex steroid replacement
on body weights and seminal vesicle weights in adolescent
male rats. (A) There were no significant differences in overall
growth between any of the five experimental groups (F=2.09, df=4,
221, p> 0.05). (B) Seminal vesicles weighed less following
gonadectomy (n=16) compared with Intact rats (n=15) and this
effect was completely prevented by T replacement (n=17), partly
prevented by DHT (n=14) but unchanged by E (n=15). * denote
comparisons with Intact, # denote comparisons with Gdx, ### and
***=p< 0.0001.
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lating estradiol we report these measurements. Average cir-
culating serum testosterone was 0.03±0.001 ng/ml in the
Gdx group (n=9), 2.8 ± 0.6 ng/ml (n=12) in the Intact
group and 23.1±12.0 ng/ml in the Gdx+T group (n=14).
Average circulating serum DHT was not detectable in
the Gdx group (n=8), 0.2 ± 0.03 ng/ml in the Intact
group (n=7), and 21.42 ± 10.6 ng/ml in the Gdx+DHT
group (n=12). Circulating serum estradiol was 7.3 ±
0.15 pg/ml (duplicate measure of 8 pooled samples) in
the Intact group and 17.0 ± 6.7 pg/ml in the Gdx+E
group (n=8).
Anatomical co-localization of AR and ER and TH in
substantia nigra dopamine neurons
Co-localization of TH and sex steroid receptors was
indicated by AR immunoreactivity in ~65.5 ± 3.5% of THpositive (TH+) neurons and ERα-immunoreactivity in
~39.9 ± 4.4% of TH+ neurons in the normal intact male
adolescent substantia nigra (50–53 days old, n=5)
(Figure 2), indicating that many dopamine neurons in
the substantia nigra could respond directly to sex steroids.
Sex steroid receptor immunoreactivity was also present in
TH negative cells.
Regulation of substantia nigra TH protein by sex steroids
TH protein was detected at the expected molecular
weight of 60 kDa and β-actin at 43 kDa (Figure 3A).
There was a significant effect of treatment group on
TH/β-actin protein levels in the substantia nigra in ado-
lescent male rats (F=4.43, df=4, p=0.0043). TH protein
in the substantia nigra was increased 70% in the Gdx+T
group relative to the Gdx group and 106% relative to the
Intact group (Figure 3B). There were no significant dif-
ferences in TH protein levels between Intact, Gdx,
Gdx+DHT or Gdx+E groups.
Regulation of substantia nigra TH mRNA by sex steroids
There was no overall effect of treatment group on TH
mRNA (F=1.97, df=4, p=0.109) in the SN of adolescent
male rats. Fisher’s LSD post hocs were run as we
hypothesized, a priori, that there would be an increase
in TH mRNA with testosterone. There was a trend for
TH mRNA to be increased in the Gdx+T group when
compared to the Intact (13.6%) and Gdx (15.4%) groups
(intact vs. Gdx+T; p=0.073; Gdx vs. Gdx+DHT, p=0.092)
(Figure 3C).
Modulation of dopamine metabolite enzyme mRNAs by
sex steroids
There was a significant effect of treatment group on
COMT (F=6.65, df=4, p < 0.0001), MAOA (F=9.983,
df=4, p < 0.0001) and MAOB (F=5.35, df=4, p < 0.001)
mRNA expression in the adolescent male rat substantia
nigra. All three breakdown enzyme mRNAs were signifi-
cantly increased in the Gdx+T and Gdx+DHT groups
when compared to the Intact or Gdx groups (all p’s
<0.05). None of the breakdown enzyme mRNA expres-
sion levels were changed in the Gdx+E group compared
to the Intact or Gdx groups (Figure 4A, B, C).
Modulation of androgen and estrogen receptor mRNAs
by sex steroids
We detected a significant effect of treatment group on
AR mRNA expression (F=11.3, df=4, p < 0.0001) in the
male SN. AR mRNA was increased by 45%, 32.5% and
26% in the Gdx+T, Gdx+DHT and Gdx+E groups, re-
spectively, compared to the Gdx group and 39.8%, 27.7%
and 21.4% in the Gdx+T, Gdx+DHT and Gdx+E groups,
respectively, compared to the Intact group (Figure 5A).

















Figure 2 AR and ERα immunoreactivity in dopamine neurons of
the adolescent male rat substantia nigra. Midbrain tissue sections
(approximately bregma −5.52) were probed with antibodies raised
against tyrosine hydroxylase (TH) and either androgen receptor
(left column) or estrogen receptor α (right column). Blue staining
indicates DAPI labeled nuclei (top row). Arrowheads indicate TH
positive neurons (green) that are also immuno-positive for sex
steroid receptors (red). Neurons with co-localized sex steroid
receptors and TH immunostaining appear yellow in the merged
images (bottom row, arrowheads). Stars indicate TH negative, sex
steroid receptor positive (red) neurons, solid arrow indicates a TH






















































































Figure 3 Effect of gonadectomy and sex steroid replacement
on TH protein and mRNA in adolescent male rats.
(A) Representative immunoblots of a subset of substantia nigra
samples from all five groups showing TH protein (60 kDa) and β-actin
protein (43 kDa). (B) TH protein was increased by testosterone (n=10)
compared to Intact (n=10) and Gdx (n=10) groups, whereas DHT (n=8)
and E (n=10) did not increase TH protein. Gdx+T was significantly
different to Gdx+DHT and Gdx+E, ***=p<0.001, and significantly
different to Gdx and Intact, p<0.05 and p<0.01, respectively. (C) TH
mRNA was measured using real time qPCR. Midbrain TH mRNA relative
expression was not significantly different according to treatment group.
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We also found a significant effect of treatment on ERα
mRNA expression (F=2.8, df=4, p=0.032) in the male
SN. ERα mRNA was significantly decreased 24.3% in the
Gdx+DHT group compared to the Intact group. There
were no significant differences in ERα mRNA relative
expression between GDX+T and GDX+E relative to the
Gdx and Intact groups. The decrease in ERα mRNA
relative expression (14.2%) in the Gdx group comparedto the Intact group did not reach statistical significance
(Intact vs. Gdx, p=0.089) (Figure 5B). We detected an ef-
fect of treatment group on ERβ mRNA expression in the
male adolescent SN (F=2.6, df=4, p=0.045). ERβ mRNA
expression was significantly increased in the Gdx+T
(27%) and Gdx+DHT (20%) groups (Figure 5C).
Modulation of sex steroid conversion enzyme mRNAs by
sex steroids
We found a significant effect of treatment group on
Cyp19A1 mRNA (F=2.8, df=4, p=0.034) with decreased
expression (40.4%) in the Gdx group compared to the
Intact group and this was not reversed by replacement
of any of the three sex steroids compared to Gdx and all
replacement groups were significantly decreased com-






























































































































Figure 4 Effect of gonadectomy and sex steroid replacement
on dopamine metabolic enzyme COMT, MAOA and MAOB
mRNA in the substantia nigra of adolescent male rats. (A) COMT
mRNA levels were significantly increased by T and DHT when
compared to both Gdx and Intact groups. (B) MAOA mRNA and (C)
MAOB mRNA levels were significantly increased by T and DHT when
compared to both Gdx and Intact groups. * denotes comparisons with
the Intact group, # denotes comparisons with the Gdx group.
* and #=p<0.05, ** and ##=p<0.01, *** and ###=p<0.0001.
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expression (F=3.76, df=4, p=0.009). Relative expression
of 5αR-1 mRNA was increased by 17.4% in the Gdx+DHT
group when compared to the Intact group. There was a
trend for 5αR-1 mRNA expression to be increased (9.7%)
in the Gdx+T group compared to the Intact group (intact
vs. Gdx+T, p=0.07) and 5αR-1 was unchanged by estradiol
(Figure 6B).
Discussion
Sex steroids have been implicated in the modulation of
neurotransmitter systems, including dopamine, albeit
with conflicting reports on the direction of change [16-
20]. The psychotic symptoms associated with schizo-
phrenia are thought to be driven by increased dopamine
neurotransmission in subcortical brain regions [1,2], but
the underlying causes of this hyperdopaminergia are un-
known. The greater prevalence of schizophrenia in males,
the peak of onset during adolescence, the increased symp-
tom severity and the earlier age of onset relative to females
[3,4,33,34] all point toward a contribution by testosterone,
which increases during male adolescence, in the etiology
of schizophrenia [35,36]. However, the mechanisms by
which testosterone contributes to the disorder in males
are uncertain. We report that TH protein as well as
COMT, MAOA and MAOB mRNA expression levels in
the substantia nigra of adolescent male rats are sensitive
to changes in testosterone via androgenic mechanisms but
appear to be relatively insensitive to changes in estrogen
alone over the male adolescent period.
Our results demonstrate the presence of ERα and AR
mRNA and protein and ERβ mRNA in the substantia
nigra of adolescent rat midbrain. Our data are in agree-
ment with previous studies demonstrating ERα [11,37]
and AR [38] in midbrain dopamine neurons (although
see [38]). Studies in adult male rats indicate that ERβ is
also expressed in the substantia nigra [10,39] and many
ERβ positive neurons are TH positive [40]. All three
receptors have been identified in the substantia nigra in
male rat pups up to postnatal day 30 (PN30) [11]. Our
study highlights that dopamine neurons of the substantia
nigra are able to respond directly to testosterone, or to
testosterone converted to estradiol, during the male ado-
lescent period.
Precisely how neurons respond to sex steroids will
depend on the type, the combination and the levels
of sex steroid receptor(s) and steroidogenic enzymes
expressed and the nature of receptor activation via ei-
ther 5α reduction and/or aromatization of testoster-
one. In our study, AR mRNA was positively regulated
by all three sex steroids, implicating both androgenic and
estrogenic mechanisms in the testosterone-induced
up-regulation of midbrain AR gene expression. In con-























































































































Figure 5 The effect of gonadectomy and sex steroid
replacement on sex steroid receptor mRNA expression in
adolescent male rat substantia nigra. (A) AR mRNA levels were
increased by T, DHT and E compared to Intact (*) and Gdx (#)
groups (n=12-14/group). (B) ERα mRNA was decreased by DHT
replacement compared to the Intact group. T and E did not change
ERα mRNA levels and were significantly different to the DHT treated
group. (C) ERβ mRNA was increased by T (compared to Intact and
Gdx groups) and by DHT (compared to Gdx only), but not by E.
*=p< 0.05, **=p< 0.01, *** and ###=p< 0.0001.
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http://www.biomedcentral.com/1471-2202/13/95androgens and not by estrogen. We found opposite andro-
gen regulation of ERα mRNA compared to ERβ mRNA
where ERα mRNA was down-regulated by DHT and ERβ
mRNA was up-regulated by testosterone and DHT. When
co-expressed with ERα, via heterodimerization with ERα,
ERβ can exert an inhibitory effect on ERα-mediated gene
expression and in many instances opposes the actions of
ERα [41,42]. Our results suggest that testosterone may co-
ordinate simultaneous changes in sex-steroid receptors to
increase responsiveness to testosterone through AR and
ERβ and reduce responsiveness through ERα via decreased
ERα and increased ERβ mRNAs.
Our data suggest that, during adolescence, testoster-
one may modulate dopaminergic tone within the sub-
stantia nigra by increasing levels of enzymes regulating
both the production and metabolism of dopamine, sug-
gestive of a local increase in dopamine utilization and
turnover within this brain region. Our data suggest that
this regulation of TH protein and COMT, MAOA and
MAOB mRNAs is not mediated via ERs, but rather
through AR. However, studies in ERα knock out mice
showed reduced levels of TH in male and female mid-
brain, indicating that significant changes in TH can be
mediated by loss of ERα [43]. In the knock out mouse,
the ERα gene is changed from early development and
the developmental trajectory driven by sex steroids of
these neurons may be very different to animals with nor-
mal ERα expression. Studies in ERβ knockout mice show
morphological abnormalities including neuronal shrinkage
and neuronal loss in the substantia nigra indicating ERβ is
important for midbrain neuronal survival [44]. Testoster-
one increased ERβ mRNA in our study, implying that tes-
tosterone can potentially contribute to ERβ mediated
effects such as neuron survival and maturation.
We did observe that pure AR stimulation through
DHT may lead to decreased TH protein levels relative to
testosterone replacement suggesting testosterone action
on TH protein levels may vary, depending on if only AR
(DHT) or both AR and ERs (testosterone) are stimu-
lated. However, the apparent lack of capacity for TH pro-
tein to be increased by DHT compared to T may also be
due to a dose effect if an inverted U-shaped dose response
curve of TH protein to AR stimulation exists, as DHT is
more potent at the AR than T and equivalent replacement
concentrations (~21 ng/ml) were achieved. This possibility
would need to be tested with further studies.
Dendritic release of dopamine in the substantia nigra
results in a feedback inhibition of dopamine neurons
that regulates their excitability [45], increased levels of
dopamine metabolic enzymes, COMT and MAOA and
B, at the cell bodies in response to increased testoster-
one, as we report here, suggests a mechanism that may
shorten the duration of feedback inhibition via released


















































































Figure 6 The effect of gonadectomy and sex steroid replacement on steroid conversion enzyme mRNA expression in adolescent male
rat substantia nigra. (A). Cyp19A1 mRNA was decreased by gonadectomy and this was not prevented by T, DHT or E replacement. * denotes
comparisons with Intact, * = p < 0.05, ** = p < 0.01 (B). 5αR-1 mRNA was increased by DHT compared to the Intact group but not by T or E
replacement. ** p =< 0.01.
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http://www.biomedcentral.com/1471-2202/13/95previous studies in adult male rats, although gonadectomy
had no effect, testosterone replacement increased COMT
activity in both cortex and striatum [46]. Testosterone
attenuated the gonadectomy-induced increase in MAOA
activity in the cortex, while MAOA activity was un-
changed in the striatum and MAOB activity was un-
changed in either region [46]. A study in intact adult male
rats treated with injections of the androgen, nandrolone,
reported decreased activity of MAOA and B with a low
dose in the dorsal striatum whereas a high dose increased
MAOB mRNA in the substantia nigra only and MAOA
and COMT mRNA levels were unchanged in all regions
[47]. Our data strengthen this existing data and demon-
strate that testosterone can contribute to changes in regu-
latory potential of dopamine neurons in the substantia
nigra. Our results highlight the potential for adolescence-
driven increases in circulating testosterone to augment
the capacity of midbrain neurons to synthesise and break
down dopamine in the normal adolescent male rat sub-
stantia nigra. We propose that in individuals with an
underlying susceptibility to schizophrenia, such as a gen-
etic variation of the COMT gene [48,49], these androgen-
driven increases in dopamine metabolic enzyme mRNAs
may contribute to dopamine dysregulation in the substan-
tia nigra at adolescence.
Other factors that may modify brain responses to in-
creasing testosterone at adolescence include changing
levels of steroidogenic enzymes. In adolescent male rats,
we report increased levels of mRNA of the enzyme that
converts T to DHT, 5αR-1, due to DHT (AR) but not es-
tradiol (ERs). Increases in local levels of 5αR steroidogenic
enzymes may increase local levels of non-aromatisable
androgens (DHT) and serve to potentiate the increase in
testosterone action via AR putatively creating a positive
feedback loop. Gonadectomy resulted in decreased aroma-
tase mRNA, responsible for converting T to E, in themidbrain, and this reduction was not reversed by replace-
ment of any sex steroid. Thus, removing the male gonads
appears to bias the midbrain toward more limited estradiol
synthesis. Our data is in contrast to the hypothalamus,
where testosterone is a major regulator of aromatase [50]
suggesting significant regional differences exist. In the sub-
stantia nigra, decreased or unchanged levels of aromatase
and increased levels of 5αR-1 in the midbrain could be
expected to shift the balance of sex steroid signaling to-
wards AR driven events, consistent with the AR-mediated
induction of AR mRNA that we find. Inhibition of 5αR ac-
tivity has been shown to counter several psychotic-like be-
havioral effects induced by apomorphine treatment in rats
[51]. As testosterone increases with the onset of puberty
more testosterone is available for reduction to DHT by
5αR-1, which in turn would be expected to increase the
level of 5αR-1 mRNA. If, as suggested, increased 5αR
(and therefore increased DHT) contributes to psychosis
[52], this positive feedback loop may trigger psychosis
in individuals with an underlying susceptibility towards
hyperdopaminergia and schizophrenia.
Deficits in prepulse inhibition (PPI, a measure of sen-
sorimotor gating that is regulated by dopamine) that result
from an inability to appropriately integrate sensory infor-
mation with a motor response, are associated with schizo-
phrenia and degree of PPI deficit can be used as an index
of schizophrenia-like behavior [53]. In contrast, we have
found that PPI was attenuated during normal male adoles-
cent development in primates [54]. Rhesus Macaques, that
had undergone prepubertal gonadectomy had a robust
PPI response, suggesting that the presence of adolescent
testosterone may induce brain and behavioral changes
which appear similar to what is found in schizophrenia
(diminished PPI) and may increase manifestation of
psychiatric-like symptoms. In rats, male castration did not
change baseline PPI in adulthood, but serotonin receptor-
Purves-Tyson et al. BMC Neuroscience 2012, 13:95 Page 10 of 12
http://www.biomedcentral.com/1471-2202/13/95stimulated changes in PPI differed in castrated rats com-
pared to testosterone replaced rats [55]. Additionally, in
adult male aromatase knockout mice (ArKO), which have
higher levels of testosterone, baseline PPI is decreased with
age when compared to controls [56]. Although PPI was
not measured in our study, our results suggest that altera-
tions in dopamine neurotransmission may contribute to
the molecular basis for how changing testosterone may
impact PPI during adolescence and confirm our observa-
tion of testosterone regulation of TH levels in the adoles-
cent male monkey striatum [54].
In summary, treatment with exogenous sex steroids,
be it T, DHT or E, shifted the adolescent male rat
midbrain to a more androgen responsive state. In
addition, increasing levels of circulating testosterone in
male adolescence could be anticipated to increase AR
mRNA, decrease ERα mRNA and increase ERβ mRNA.
The underlying susceptibility to schizophrenia may in-
volve the inability of the brain to respond appropriately
to sex steroids [57], which is unmasked at adolescence.
For example, either lower endogenous ERα [57] and/or
increased AR signaling could be exaggerated by adoles-
cent testosterone and thus, testosterone could shift the
individual toward a dysregulated dopaminergic state. As
yet, the levels of sex steroid receptors or sex steroid con-
version enzymes have not been specifically measured in
the midbrain of patients with schizophrenia.
Conclusions
In conclusion, the mechanism of testosterone action in
the adolescent male rat substantia nigra includes regula-
tion of TH levels and dopamine metabolic enzymes as
well as modulation of sex steroid signaling by controlling
levels of sex steroid receptor and androgen activating en-
zyme gene expression. Understanding how testosterone
action modulates synthesis of sex steroid receptors and
androgen activation in the normal adolescent male sub-
stantia nigra increases our understanding of the potential
role of sex steroids in dopamine neuron activity at adoles-
cence and how sex steroids may contribute to psychopath-
ology involving dopamine dysregulation.
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